Skip to main content

Advertisement

Table 2 Genotype distribution and allele frequency for FOXA2 rs1209523 among patients with T2D and glucose-tolerant control individuals

From: The effect of FOXA2rs1209523 on glucose-related phenotypes and risk of type 2 diabetes in Danish individuals

  n (men/women) CC (%) CT (%) TT (%) MAF (95% CI) OR (95% CI) P add
All individuals        
NGT 4,875 (2,256/2,619) 4,567 (93.7) 300 (6.2) 8 (0.2) 3.2 (2.9-3.6) 0.82 (0.62-1.07) 0.1
T2D 3,507 (2,084/1,423) 3,340 (95.2) 166 (4.7) 1 (0.1) 2.4 (2.1-2.8)   
Non-obese individuals (BMI < 30 kg/m 2 )        
NGT 4,292 (1,999/2,293) 4,012 (93.5) 272 (6.3) 8 (0.2) 3.4 (3.0-3.8) 0.68 (0.49-0.94) 0.02
T2D 1,730 (1,096/634) 1,653 (95.5) 77 (4.5) 0 (0) 2.2 (1.8-2.8)   
  1. Number of individuals divided into genotype groups (% in each group), and frequencies of the minor allele (MAF) in percentages. Logistic regression was used to compare allele frequencies (P add ). The odds ratios (OR) and the 95% confidence interval (CI) are given for comparison of allele frequency. NGT: Glucose-tolerant individuals, T2D: type 2 diabetic patients.